Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may cause a common type of hair loss called telogen effluvium.

Dilated scalp capillaries might be a sign of hair loss related to COVID-19.

COVID-19 infection may cause hair loss a few months after recovery.

Telogen effluvium is a condition that causes temporary hair loss due to stress or shock to the body.

Homoeopathy has helped treat hair loss after Covid-19, considering the patient's overall condition.

Platelet-Rich Plasma therapy helped significantly in hair recovery for a hair loss condition after infection.

Hair loss is a symptom of long COVID and can be treated with a protein-rich diet.

COVID-19 may cause increased hair loss, but the exact reason is unclear and standard hair loss treatments are recommended.

COVID-19 can cause temporary hair loss, known as Telogen Effluvium, within two months of infection.

To diagnose hair loss, use a systematic approach including history, exams, and tests.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

The COVID-19 pandemic led to an increase in untreated hair diseases and showed the importance of teledermatology.

Hair loss in teenagers is hard to treat and lacks a cure, with some treatments available depending on the type of hair loss.

Trichoscopy is good for telling apart tinea capitis and alopecia areata in kids.

Occipital scalp affects female hair loss; terminal/vellus ratio helps diagnose androgenetic alopecia.

Imiquimod cream can rarely cause temporary hair loss.

Heavy metals might contribute to hair loss in Telogen Effluvium.

Testosterone and its metabolites have varied effects on different body systems, especially during puberty.

Combining PRP with Tressfix Serum is more effective for hair regrowth in telogen effluvium than using either alone.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.

Most lab tests for patients with Telogen effluvium, a type of hair loss, show no or mild abnormalities; only a few specific tests are useful.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.

The conclusion is that examining the scalp closely and checking for iron levels and thyroid issues is key to understanding chronic hair loss in women.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

The marine protein complex, Viviscal®, was found to effectively reduce hair loss and improve hair, skin, and nails quality in women.

Alopecia common in teens, may indicate endocrine issue, minoxidil effective treatment.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

The COVID-19 pandemic led to fewer patient visits, more visits by older adults, an increase in cutaneous T-cell lymphoma cases, and a rise in noncosmetic procedures at a dermatology clinic.